I have all the content from the PDF. Here is a complete, easy-to-understand explanation of everything covered:
π§ͺ Antihistaminic Agents - Simple Explanation
1. What is Histamine?
Histamine is a chemical messenger naturally found in your body - mainly in the lungs, skin, blood vessels, and gut. Your body makes it in mast cells and basophils (types of immune cells), in the stomach lining, and in brain nerve cells.
Think of histamine as an alarm signal. When your body detects something harmful (like an allergen), mast cells release histamine, which then triggers a chain of reactions.
2. What Does Histamine Do? (Its Receptors)
Histamine works by attaching to specific receptors, like a key fitting into a lock:
| Receptor | What it does |
|---|
| H1 | Causes allergic reactions, inflammation, keeps you awake |
| H2 | Tells your stomach to make more acid |
| H3 | Acts as an "off switch" in the brain - controls neurotransmitter release |
| H4 | Found on immune cells (eosinophils, mast cells) - drives allergic responses |
Physical effects of histamine release:
- Blood vessels: Large arteries constrict; small capillaries dilate β blood pressure drops
- Brain blood vessels: Dilate β causes throbbing headaches
- Stomach: Increases acid secretion
- Airways: Causes bronchospasm (narrowing of airways β difficulty breathing)
- Skin: Classic "Triple Response" = Flush (redness) + Flare (spreading redness) + Wheal (raised bump)
3. Chemistry of Histamine (Simplified)
Histamine has two basic (alkaline) parts:
- The imidazole ring (a 5-membered ring with nitrogen)
- The aliphatic amine group (a side chain with -NH2)
At the body's normal pH (7.4), histamine exists mainly as a monocation (single positive charge on the side chain). This charged form is the active, working form.
Tautomers (two slightly different forms that switch back and forth):
- In water: 80% NΟ-H form, 20% NΟ-H form
- In solid crystals: the NΟ-H form is preferred
Shape (conformation) matters:
- Trans shape β binds H1 and H2 receptors
- Gauche shape β selectively binds H3 receptors
4. How Histamine is Made in the Body
Histidine (an amino acid from food) β Histidine Decarboxylase enzyme (needs Vitamin B6/pyridoxal phosphate as helper) β Histamine
This happens inside the Golgi apparatus of mast cells and basophils.
Histamine is broken down by:
- Diamine oxidase
- Histamine N-methyl transferase
- Aldehyde dehydrogenase / Aldehyde oxidase
5. Classification of Antihistaminic Drugs
Antihistaminic Agents
βββ H1 Receptor Antagonists
β βββ 1st Generation (older, cause sedation)
β βββ 2nd Generation (newer, non-sedating)
βββ H2 Receptor Antagonists (reduce stomach acid)
βββ Proton Pump Inhibitors (most powerful acid suppressors)
6. H1 Receptor Antagonists - 1st Generation
These older drugs block H1 receptors but also accidentally block other receptors (cholinergic, dopaminergic, etc.), causing many side effects.
Uses: Hay fever, rhinitis (runny nose), urticaria (hives), food allergies
Side effects:
- CNS: Sedation, drowsiness, poor concentration (they cross into the brain)
- Peripheral (anticholinergic): Dry mouth, blurred vision, constipation, difficulty urinating
All these drugs are technically inverse agonists - they don't just block histamine, they actually quiet down the receptor's natural activity.
Structural Classes of 1st Generation H1 Antihistamines
All 1st generation H1 drugs share a common skeleton:
- Two aromatic rings (Ar1, Ar2) - can be phenyl, pyridyl, or thienyl
- A central atom X
- A 2-3 carbon spacer
- A terminal amine (NR2)
The X atom defines the class:
A. Ethylenediamines (X = N)
- Examples: Tripelenamine, Phenbenzamine
- Nitrogen connects the two aromatic groups
B. Ethanolamines / Benzhydryl Ethers (X = C-O)
- Examples: Diphenhydramine (common antiallergy drug), Clemastine
- Diphenhydramine + 8-chlorotheophylline = Dimenhydrinate (used for motion sickness)
- Strong anticholinergic side effects (dry mouth, blurred vision, fast heart rate)
C. Alkylamines (X = CH)
- Examples: Chlorpheniramine, Triprolidine, Phenindamine
- Widely sold over-the-counter for mild seasonal allergies
- Longer duration of action + less sedation than the above two classes
- Interesting: E-isomer (trans) of triprolidine is 1,000 times more potent than Z-isomer, because a specific distance (5-6 Angstroms) between the amine and the aromatic ring is needed for receptor binding
D. Piperazines
- Examples: Hydroxyzine, Cetirizine
- Combine features of ethylenediamine and benzhydryl ether classes - the 2-carbon nitrogen separation is built into a piperazine ring
- Used for: motion sickness, vertigo, nausea/vomiting (antiemetic effects)
- Hydroxyzine: treats itching (pruritus); at higher doses, treats anxiety
- Cetirizine = active metabolite of hydroxyzine; has both an amine group and a -COOH group so it exists as a zwitterion (both + and - charge); less sedating
E. Tricyclics
- Formed by connecting two aromatic rings with a bridge (S, O, or 1-2 carbons)
- Distinguished from antipsychotic phenothiazines by having a shorter, branched side chain (2-3 carbons) vs. antipsychotics which have a long unbranched 3-carbon chain
- Used for dry cough and motion sickness
7. H1 Receptor Antagonists - 2nd Generation
These are the modern, improved antihistamines. Here's what makes them better:
| Feature | 1st Generation | 2nd Generation |
|---|
| Sedation | Yes (cross blood-brain barrier) | No (cannot cross BBB) |
| Anticholinergic effects | Yes | Minimal |
| Selectivity | Low (hit multiple receptors) | High (mainly H1 only) |
| Nature | Lipophilic | Amphoteric/Zwitterionic |
Why don't they cause sedation? They are amphoteric (zwitterionic at body pH) - they carry both a positive and negative charge at the same time. This makes them unable to cross the blood-brain barrier easily.
Key 2nd Generation Drugs:
-
Terfenadine and Astemizole: Early 2nd generation drugs - both withdrawn from markets due to cardiotoxicity (dangerous heart rhythm problems - QT prolongation)
-
Fexofenadine: Active metabolite of terfenadine. Safe - no cardiotoxicity.
-
Loratadine: Related to 1st generation tricyclics but non-sedating and no cardiotoxicity. IUPAC: 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohept[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester
- Metabolized to Desloratadine by oxidation (NOT hydrolysis - important exam point!)
-
Desloratadine: Active metabolite of loratadine. More potent H1 antagonist, better at blocking histamine release, non-sedating, no cardiotoxicity.
-
Cetirizine: Active metabolite of hydroxyzine (1st gen). Has amphoteric nature (zwitterion). Less sedating than hydroxyzine but not completely non-sedating.
-
Levocetirizine: The R-enantiomer of cetirizine. Has 30 times higher affinity for H1 receptor than the S-enantiomer. Also dissociates from the receptor much more slowly (20-fold), meaning it works longer.
8. H2 Receptor Antagonists
These drugs block H2 receptors in the stomach's parietal cells, reducing acid production.
Uses: Duodenal ulcers, gastric ulcers, GERD, acid reflux, H. pylori treatment (as part of combination therapy), pre-surgery acid prevention
How They Were Developed (Story of Drug Design):
- Histamine itself activates H2 receptors and stimulates acid
- Adding a methyl group at position 5 of histamine's imidazole ring β selective H2 agonist
- Replacing the amine group with a guanidino group β weak H2 antagonist
- Making the side chain longer (2 β 4 carbons) + replacing guanidino with methyl thiourea β Burimamide (first full H2 antagonist, but too weak for clinical use)
- Adding a thioether group + 5-methyl on ring β Metiamide (stronger, better bioavailability, but caused agranulocytosis - dangerous white blood cell drop)
- Replacing thiourea with cyano-imino group β Cimetidine (first clinically safe and effective H2 blocker!)
Key H2 Blockers:
- Cimetidine: First H2 blocker. Problems: anti-androgenic effects (causes gynecomastia - male breast growth), inhibits liver enzymes (cytochrome P450) causing drug interactions, short-acting.
- Ranitidine: Replaced imidazole with furan ring. Fewer side effects than cimetidine. Metabolites (N-oxide, S-oxide, desmethyl ranitidine) are inactive.
- Famotidine/Nizatidine: Use thiazole ring with guanidine substituents - even more potent and selective, fewer cytochrome P450 interactions.
- Lafutidine: Newer H2 blocker with a pyridyl group.
9. Proton Pump Inhibitors (PPIs)
These are the most powerful acid suppressors available. They don't just block receptors - they directly shut off the acid pump itself.
Basic structure: Pyridylmethylsulfinyl benzimidazole (a combination of a pyridine ring + sulfinyl group + benzimidazole ring)
Uses: Duodenal and gastric ulcers, GERD, erosive esophagitis, Zollinger-Ellison syndrome (rare tumor causing massive acid overproduction)
How PPIs Work (Mechanism of Action):
- PPIs are prodrugs - they are inactive when swallowed
- They need an acidic environment to activate (only found in the acid-secreting pocket of parietal cells)
- In this acidic environment, the benzimidazole ring rearranges into a reactive sulfenamide (active form)
- This active form covalently binds (permanent bond) to cysteine residues (especially Cys-813) on the H+/K+-ATPase pump (the proton pump)
- This permanently inactivates the pump
- Since the binding is irreversible, acid secretion stops completely until the body makes new pump proteins
Key advantage over H2 blockers: PPIs block the final step of acid production (the pump itself), so they work regardless of what stimulated acid secretion (histamine, gastrin, or acetylcholine). They block both basal (resting) and stimulated acid secretion.
Why PPIs are Given as Enteric-Coated Tablets:
PPIs are unstable in acid (they'd activate prematurely in the stomach before reaching parietal cells). So they're formulated as delayed-release enteric-coated capsules/tablets that only dissolve in the alkaline small intestine, protecting the drug until it reaches the bloodstream and then the parietal cells.
Common PPIs:
All are amphoteric (weak base pyridine N + weak acid benzimidazole NH):
| Drug | Key Feature |
|---|
| Omeprazole | First PPI; has S-enantiomer called Esomeprazole |
| Lansoprazole | Contains trifluoroethoxy group on pyridine ring |
| Pantoprazole | Has difluoromethoxy group; N-oxide is major metabolite (pink color) |
| Rabeprazole | Has methoxypropoxy group; sodium salt form |
10. Mast Cell Stabilizers (Inhibitors of Histamine Release)
Instead of blocking histamine after it's released, these drugs prevent histamine from being released in the first place.
How they work: Stabilize the granule membranes inside mast cells, stopping exocytosis (the process of dumping histamine out of the cell). They also prevent release of leukotrienes (C4, D4, E4) and prostaglandins - other inflammatory chemicals.
Example: Cromolyn (Sodium Cromoglycate)
- Used prophylactically (preventively, not to treat an attack already happening)
- Inhaled powder for bronchial asthma prevention
- Prevents exercise-induced bronchospasm
- Nasal solution for seasonal/perennial allergic rhinitis
Quick Summary Table
| Drug Class | Examples | Main Use | Key Feature |
|---|
| H1 Antihistamines (1st gen) | Diphenhydramine, Chlorpheniramine, Hydroxyzine | Allergies, colds, motion sickness | Sedating; anticholinergic side effects |
| H1 Antihistamines (2nd gen) | Cetirizine, Loratadine, Fexofenadine | Allergies | Non-sedating; no anticholinergic effects |
| H2 Antagonists | Cimetidine, Ranitidine, Famotidine | Ulcers, GERD, acid reflux | Reduce stomach acid via receptor block |
| Proton Pump Inhibitors | Omeprazole, Pantoprazole, Lansoprazole | Severe GERD, ulcers, ZE syndrome | Irreversibly block the acid pump |
| Mast Cell Stabilizers | Cromolyn | Asthma prevention, allergic rhinitis | Prevent histamine release |
This covers the entire PDF in simple, organized language. Let me know if you'd like a deeper explanation of any specific section!